Sponsored Links

Topaz Pharmaceuticals Announces New Drug Application For The Treatment Of Head Lice Accepted By FDA PDF Print E-mail
Pharmacy - Pharma Industry - Biotech Industry
Topaz Pharmaceuticals Inc., a privately held specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug Application (NDA) for the use of ivermectin topical cream as a treatment for head lice infestations in children and adults...

Read more: Pharma Industry / Biotech Industry News From Medical News Today